27. April 2021 – On the advice of the Swiss National COVID-19 Task Force, the Federal Office of Public Health has signed a contract with Roche Pharma (Switzerland) Ltd to purchase a promising drug to treat coronavirus (SARS-CoV-2). It is a combination of monoclonal antibodies. The first deliveries are planned for mid-May. The contract value is confidential.

For more information, see here.